Related Experiment Videos
Genetic determinants of bone mass.
L Audí1, M García-Ramírez, A Carrascosa
1Unidad de Investigaciones en Endocrinología y Nutrición Pediátricas, Hospital Materno-Infantil Valle de Hebrón, Universidad Autónoma de Barcelona, Spain. laudi@cs.vhebron.es
Hormone Research
|August 26, 1999
Summary
Genetic factors influence bone mass, but associations between specific gene variations and bone mineral density (BMD) remain unclear. Further research is needed to understand the molecular basis of genetic contributions to bone health.
Area of Science:
- Genetics and Bone Metabolism
- Molecular Biology
- Osteoporosis Research
Background:
- Genetic contributions to bone mass were recognized decades ago.
- Numerous genes involved in bone metabolism have been studied for their association with bone mineral density (BMD).
- The vitamin D receptor (VDR) gene was an early focus, but its exact role in BMD variation is debated.
Purpose of the Study:
- To review the current understanding of gene polymorphisms and their association with bone mass.
- To highlight the ongoing challenges in elucidating the molecular mechanisms linking gene variations to BMD.
- To explore alternative approaches like linkage analysis in identifying genes related to bone density.
Main Methods:
- Analysis of polymorphic variations in candidate genes related to bone metabolism (e.g., VDR, estrogen receptor, collagen type 1alpha1).
- Association studies correlating gene polymorphisms with BMD measurements.
- Linkage analysis in families with low BMD to identify genetic loci influencing bone density.
Main Results:
- Conflicting evidence exists regarding the association between VDR gene polymorphisms and BMD.
- Some studies report associations between variations in other bone metabolism genes and BMD, particularly when combined.
- Linkage analysis in specific pedigrees has not confirmed associations with previously implicated genes, suggesting novel genetic factors.
Conclusions:
- The precise molecular basis for the influence of gene polymorphisms on bone mineralization remains largely undefined.
- Genetic factors contributing to normal BMD variations may differ significantly from those causing pathological BMD levels.
- Further research is required to identify novel genes and understand the complex genetic architecture of bone mass determination.